Lexicon Pharmaceuticals

LXRX

LXRX
Lexicon Pharmaceuticals Stock Quote
$6.06 $0.24 4.1%
BATS BZX Real Time Price as of May 21, 2019, 2:29 p.m. View Interactive LXRX Charts

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

News & Analysis: Lexicon Pharmaceuticals

The Fool has written over 100 articles on Lexicon Pharmaceuticals.

All

Market Moves

Earnings


What's Next for Lexicon Pharmaceuticals?

American regulators rejected a type 1 diabetes treatment that analysts predicted would eventually eclipse $450 million in annual revenue.









3 Top Biotech Stocks to Buy in December

Find out why our healthcare contributors believe that these biotechs are great buys right now.


Interactive Chart